Your browser doesn't support javascript.
loading
The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease: Signalling pathway and novel therapeutic targets.
Iring, András; Tóth, Adrián; Baranyi, Mária; Otrokocsi, Lilla; Módis, László V; Gölöncsér, Flóra; Varga, Bernadett; Hortobágyi, Tibor; Bereczki, Dániel; Dénes, Ádám; Sperlágh, Beáta.
Afiliação
  • Iring A; Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, 1083 Budapest, Hungary.
  • Tóth A; Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, 1083 Budapest, Hungary; János Szentágothai School of Neurosciences, Semmelweis University School of Ph.D. Studies, 1085 Budapest, Hungary; Department of Neurology, Faculty of Medicine, Semmelweis University, 1083 Budapest, Hun
  • Baranyi M; Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, 1083 Budapest, Hungary.
  • Otrokocsi L; Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, 1083 Budapest, Hungary.
  • Módis LV; MTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neurology, University of Debrecen, 4032 Debrecen, Hungary.
  • Gölöncsér F; Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, 1083 Budapest, Hungary.
  • Varga B; Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, 1083 Budapest, Hungary; János Szentágothai School of Neurosciences, Semmelweis University School of Ph.D. Studies, 1085 Budapest, Hungary.
  • Hortobágyi T; MTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neurology, University of Debrecen, 4032 Debrecen, Hungary; Institute of Pathology, Faculty of Medicine, University of Szeged, 6725 Szeged, Hungary; Department of Old Age Psychiatry, Institute of Psychiatry Psychology and Neur
  • Bereczki D; Department of Neurology, Faculty of Medicine, Semmelweis University, 1083 Budapest, Hungary.
  • Dénes Á; Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, 1083 Budapest, Hungary.
  • Sperlágh B; Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, 1083 Budapest, Hungary; János Szentágothai School of Neurosciences, Semmelweis University School of Ph.D. Studies, 1085 Budapest, Hungary. Electronic address: sperlagh@koki.hu.
Pharmacol Res ; 176: 106045, 2022 02.
Article em En | MEDLINE | ID: mdl-34968684
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Parkinsonianos / Receptores Purinérgicos P2Y12 Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hungria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Parkinsonianos / Receptores Purinérgicos P2Y12 Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hungria